ORRs
| . | HCT (n = 14) . | SOT (n = 12) . | Total (N = 26) . |
|---|---|---|---|
| Best overall response, n (%) | |||
| CR | 4 (28.6) | 6 (50.0) | 10 (38.5) |
| PR | 3 (21.4) | 4 (33.3) | 7 (26.9) |
| SD | 2 (14.3) | 1 (8.3) | 3 (11.5) |
| PD | 4 (28.6) | 1 (8.3) | 5 (19.2) |
| NE | 1 (7.1)∗ | 0 | 1 (3.8)∗ |
| Responders, n (%) | 7 (50.0) | 10 (83.3) | 17 (65.4) |
| 95% CI | 23.0-77.0 | 51.6-97.9 | 44.3-82.8 |
| . | HCT (n = 14) . | SOT (n = 12) . | Total (N = 26) . |
|---|---|---|---|
| Best overall response, n (%) | |||
| CR | 4 (28.6) | 6 (50.0) | 10 (38.5) |
| PR | 3 (21.4) | 4 (33.3) | 7 (26.9) |
| SD | 2 (14.3) | 1 (8.3) | 3 (11.5) |
| PD | 4 (28.6) | 1 (8.3) | 5 (19.2) |
| NE | 1 (7.1)∗ | 0 | 1 (3.8)∗ |
| Responders, n (%) | 7 (50.0) | 10 (83.3) | 17 (65.4) |
| 95% CI | 23.0-77.0 | 51.6-97.9 | 44.3-82.8 |
A patient is considered a responder if the best overall response is either CR or PR.
NE, not evaluable; PD, progressive disease.
No disease assessment obtained.